Abraham E (2000) NF-kappaB activation. Crit Care Med 28(4 Suppl):N100–N104. https://doi.org/10.1097/00003246-200004001-00012

Article  CAS  PubMed  Google Scholar 

Aguilera-Carbo A, Augur C, Prado-Barragan LA, Favela-Torres E, Aguilar CN (2008) Microbial production of ellagic acid and biodegradation of ellagitannins. Appl Microbiol Biotechnol 78(2):189–199. https://doi.org/10.1007/s00253-007-1276-2

Article  CAS  PubMed  Google Scholar 

Bala I, Bhardwaj V, Hariharan S, Kumar MN. (2006) Analytical methods for assay of ellagic acid and its solubility studies. J Pharm Biomed Ana` 40(1):206–10. https://doi.org/10.1016/j.jpba.2005.07.006.

Baradaran Rahimi V, Ghadiri M, Ramezani M, Askari VR (2020) Antiinflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: evidence from cellular, animal, and clinical studies. Phytother Res 34(4):685–720. https://doi.org/10.1002/ptr.6565

Article  PubMed  Google Scholar 

Bertelsen T, Ljungberg C, Boye Kjellerup R, Iversen L, Johansen C (2017) IL-17F regulates psoriasis-associated genes through IκBζ. Exp Dermatol 26(3):234–241. https://doi.org/10.1111/exd.13182

Article  CAS  PubMed  Google Scholar 

Brembilla NC, Senra L, Boehncke WH (2018) The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol 2(9):1682. https://doi.org/10.3389/fimmu.2018.01682

Article  CAS  Google Scholar 

D’Amico F, Skarmoutsou E, Granata M, Trovato C, Rossi GA, Mazzarino MC (2016) S100A7: a rAMPing up AMP molecule in psoriasis. Cytokine Growth Factor Rev 32:97–104. https://doi.org/10.1016/j.cytogfr.2016.01.002

Article  CAS  PubMed  Google Scholar 

Danielsen K, Olsen AO, Wilsgaard T, Furberg AS (2013) Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol 168(6):1303–1310. https://doi.org/10.1111/bjd.12230

Article  CAS  PubMed  Google Scholar 

Derosa G, Maffioli P, Sahebkar A (2016) Ellagic acid and its role in chronic diseases. Adv Exp Med Biol 928:473–479. https://doi.org/10.1007/978-3-319-41334-1_20

Article  CAS  PubMed  Google Scholar 

Furue K, Ito T, Tsuji G, Nakahara T, Furue M (2020) The CCL20 and CCR6 axis in psoriasis. Scand J Immunol 91(3):e12846. https://doi.org/10.1111/sji.12846

Article  PubMed  Google Scholar 

Gil TY, Hong CH, An HJ (2021) Anti-Inflammatory effects of ellagic acid on keratinocytes via MAPK and STAT pathways. Int J Mol Sci 22(3):1277. https://doi.org/10.3390/ijms22031277

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB (2016) Psoriasis. Nat Rev Dis Primers 24(2):16082. https://doi.org/10.1038/nrdp.2016.82

Article  Google Scholar 

Gutowska-Owsiak D, Schaupp AL, Salimi M, Selvakumar TA, McPherson T, Taylor S, Ogg GS (2012) IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Exp Dermatol 21(2):104–110. https://doi.org/10.1111/j.1600-0625.2011.01412.x

Article  CAS  PubMed  Google Scholar 

Hattori F, Kiatsurayanon C, Okumura K, Ogawa H, Ikeda S, Okamoto K, Niyonsaba F (2014) The antimicrobial protein S100A7/psoriasin enhances the expression of keratinocyte differentiation markers and strengthens the skin’s tight junction barrier. Br J Dermatol 171(4):742–753. https://doi.org/10.1111/bjd.13125

Article  CAS  PubMed  Google Scholar 

Hawkes JE, Chan TC, Krueger JG (2017) Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol 140(3):645–653. https://doi.org/10.1016/j.jaci.2017.07.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoang SH, Dao H, Lam EM (2023) A network pharmacology approach to elucidate the anti-inflammatory effects of ellagic acid. J Biomol Struct Dyn 31:1–12. https://doi.org/10.1080/07391102.2023.2240417

Article  CAS  Google Scholar 

Huang Q, Chai WM, Ma ZY, Deng WL, Wei QM, Song S, Zou ZR, Peng YY (2019) Antityrosinase mechanism of ellagic acid in vitro and its effect on mouse melanoma cells. J Food Biochem 43(11):e12996. https://doi.org/10.1111/jfbc.12996

Article  PubMed  Google Scholar 

Jiang S, Hinchliffe TE, Wu T (2015) Biomarkers of an autoimmune skin disease-psoriasis. Genom Proteom Bioinform 13(4):224–233. https://doi.org/10.1016/j.gpb.2015.04.002

Article  CAS  Google Scholar 

Jin L, Wang G (2014) Keratin 17: a critical player in the pathogenesis of psoriasis. Med Res Rev 34(2):438–454. https://doi.org/10.1002/med.21291

Article  CAS  PubMed  Google Scholar 

Johansen C, Bertelsen T, Ljungberg C, Mose M, Iversen L (2016) Characterization of TNF-α- and IL-17A-mediated synergistic induction of DEFB4 gene expression in human keratinocytes through IκBζ. J Invest Dermatol 136(8):1608–1616. https://doi.org/10.1016/j.jid.2016.04.012

Article  CAS  PubMed  Google Scholar 

Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, Harper RW, Wu R (2004) IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173(5):3482–3491. https://doi.org/10.4049/jimmunol.173.5.3482

Article  CAS  PubMed  Google Scholar 

Kilic I, Yeşiloğlu Y, Bayrak Y (2014) Spectroscopic studies on the antioxidant activity of ellagic acid. Spectrochim Acta A Mol Biomol Spectrosc 15(130):447–452. https://doi.org/10.1016/j.saa.2014.04.052

Article  CAS  Google Scholar 

Kim MR, Hwang HS (2021) Brazilin downregulates CCL20 expression via regulation of STAT3 phosphorylation in TNF-α/IL-17A/IFN-γ-induced HaCaT cells Journal of applied biological chemistry. Korean Soc Appl Biol Chem. https://doi.org/10.3839/jabc.2021.027

Article  Google Scholar 

Kolbinger F, Loesche C, Valentin MA, Jiang X, Cheng Y, Jarvis P, Peters T, Calonder C, Bruin G, Polus F, Aigner B, Lee DM, Bodenlenz M, Sinner F, Pieber TR, Patel DD (2017) β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis. J Allergy Clin Immunol 139(3):923-932.e8. https://doi.org/10.1016/j.jaci.2016.06.038

Article  CAS  PubMed  Google Scholar 

Lipińska L, Klewicka E, Sójka M (2014) The structure, occurrence and biological activity of ellagitannins: a general review. Acta Sci Pol Technol Aliment 13(3):289–299. https://doi.org/10.17306/j.afs.2014.3.7

Article  PubMed  Google Scholar 

Lowes MA, Suárez-Fariñas M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 2014(32):227–255. https://doi.org/10.1146/annurev-immunol-032713-120225

Article  CAS  Google Scholar 

Morizane S, Gallo RL (2012) Antimicrobial peptides in the pathogenesis of psoriasis. J Dermatol 39(3):225–230. https://doi.org/10.1111/j.1346-8138.2011.01483.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nukui T, Ehama R, Sakaguchi M, Sonegawa H, Katagiri C, Hibino T, Huh NH (2008) S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. J Cell Biochem 104(2):453–464. https://doi.org/10.1002/jcb.21639

Article  CAS  PubMed  Google Scholar 

Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M (2021) Skin barrier dysregulation in psoriasis. Int J Mol Sci 22(19):10841. https://doi.org/10.3390/ijms221910841

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parisi R, Symmons DP (2012) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133(2):377–385. https://doi.org/10.1038/jid.2012.339

Article  CAS  PubMed